FN2 Earnings Intelligence
Xylem Inc. balance sheet (quarterly)
Xylem Inc. (XYL) Balance Sheet (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,059 | $1,170 | $1,191 | $808 | $1,276 | - | - |
| + Debt | $2,015 | $1,996 | $1,962 | $1,938 | $2,926 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $2,069 | $2,301 | $2,268 | $2,125 | $2,336 | $2,288.5 | $2,454.5 |
| % Growth | - | - | - | - | - | 0.9% | - |
| Gross Profit | $768 | $892 | $883 | $803 | $963 | - | - |
| % Margin | 37.1% | 38.8% | 38.9% | 37.8% | 41.2% | - | - |
| EBITDA | $299 | $450 | $476 | $309 | $530 | - | - |
| % Margin | 14.5% | 19.6% | 21.0% | 14.5% | 22.7% | - | - |
| Net Income | $169 | $226 | $227 | $193 | $263 | - | - |
| % Margin | 8.2% | 9.8% | 10.0% | 9.1% | 11.3% | - | - |
| Diluted EPS | $0.69 | $0.93 | $0.93 | $0.79 | $1.11 | $1.45 | $1.65 |
| % Growth | - | - | - | - | - | 56.2% | - |
| Operating Cash Flow | $33 | - | - | $108 | - | - | - |
| CapEx | $71 | $98 | $79 | $90 | - | - | - |
| Free Cash Flow | -$38 | - | - | $18 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $2,069 | $2,301 | $2,268 | $2,125 | $2,336 | $2,288.5 | $2,454.5 |
| Gross Profit | $768 | $892 | $883 | $803 | $963 | - | - |
| EBITDA | $299 | $450 | $476 | $309 | $530 | - | - |
| Net Income | $169 | $226 | $227 | $193 | $263 | - | - |
| Diluted EPS | $0.69 | $0.93 | $0.93 | $0.79 | $1.11 | $1.45 | $1.65 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,059 | $1,170 | $1,191 | $808 | $1,276 |
| Short-term Debt | $41 | $68 | $49 | $531 | $531 |
| Long-term Debt | $1,974 | $1,928 | $1,913 | $1,407 | $2,395 |
| Total Debt | $2,015 | $1,996 | $1,962 | $1,938 | $2,926 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $33 | - | - | $108 | - |
| Capital Expenditure | $71 | $98 | $79 | $90 | - |
| Free Cash Flow | -$38 | - | - | $18 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 37.1% | 38.8% | 38.9% | 37.8% | 41.2% |
| EBITDA Margin | 14.5% | 19.6% | 21.0% | 14.5% | 22.7% |
| Net Margin | 8.2% | 9.8% | 10.0% | 9.1% | 11.3% |
| FCF Margin | -1.8% | - | - | 0.8% | - |
| Diluted EPS Growth | - | - | - | - | - |